2005
DOI: 10.1007/s11060-005-5531-z
|View full text |Cite
|
Sign up to set email alerts
|

Local Intracerebral Administration of Paclitaxel with the Paclimer® Delivery System: Toxicity Study in a Canine Model

Abstract: Introduction: Paclitaxel, a microtubule binding agent with potent anti-glioma activity in vitro, exhibits poor penetrance to the CNS when delivered systemically. To minimize toxicity and reach therapeutic concentrations in the CNS, paclitaxel was previously incorporated into biodegradable microspheres (Paclimer®), and the efficacy of Paclimer® was determined in a rat model of malignant glioma. In this study we report the safety of intracranial Paclimer® in a canine dose escalation toxicity study to prepare its… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
23
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(24 citation statements)
references
References 32 publications
1
23
0
Order By: Relevance
“…A biodegradable polymer PTX microsphere, Paclimer, was developed and examined in various cancer xenografts and patients with ovarian cancer (24,25). Paclimer contains 10% PTX (w/w) with microspheres ranging in size between 20 to 200 Am in diameter (median diameter of 53 Am).…”
Section: Discussionmentioning
confidence: 99%
“…A biodegradable polymer PTX microsphere, Paclimer, was developed and examined in various cancer xenografts and patients with ovarian cancer (24,25). Paclimer contains 10% PTX (w/w) with microspheres ranging in size between 20 to 200 Am in diameter (median diameter of 53 Am).…”
Section: Discussionmentioning
confidence: 99%
“…In order to achieve a prolonged period of function, maximized efficiency, and minimized unwanted side effects to healthy tissues, methods such as local and sustained postsurgical drug delivery have been explored. 101 Electrospun fabrics loaded with anticancer drugs can be conveniently inserted to cover the solid tumor site, and this not only provides high local dosage with incorporation of small amounts of the drug but also reduces the need for frequent administrations, resulting in patient convenience.…”
Section: Cancer Therapymentioning
confidence: 99%
“…The limited ability of most chemotherapeutic agents to penetrate the blood-brain barrier (BBB) (1)(2)(3)(4) has been addressed by the development of polymeric devices for local delivery of chemotherapeutic agents (5)(6)(7); these devices bypass the BBB while reducing the risk of systemic toxicity effects.…”
Section: Introductionmentioning
confidence: 99%